Dunkin’ Brands Group (DNKN), the parent of two fast-food restaurant companies Dunkin’ Donuts (DD) and Baskin-Robbins (BR) named Dave Hoffmann as its new CEO with immediate effect. The outgoing CEO Nigel Travis is retiring from the company and has been appointed Executive Chairman of the Board of Directors.
Hoffman joined Dunkin’ in late 2016 as President of Dunkin’ Donuts. Before joining the doughnut and coffee chain, he was working in McDonald’s (MCD) as President, High Growth Markets. When he left McDonald’s, it was reported that he lost above $20 million of his compensation since he didn’t sign the non-compete agreement.

Nigel Travis, who has been working as the CEO of Dunkin’ for almost a decade, will be retiring as the CEO and will remain active with the company as Executive Chairman. The company went public in 2011 under his leadership and has given back about $2.7 billion to shareholders since that time. In his new role, Travis will look after the development of the holding restaurant company’s international businesses.
The Canton, Massachusetts-based company is planning to conduct a conference call today at 4:30 PM ET to discuss the management change. Shares of Dunkin’, which inched up 0.6% on Tuesday, slipped about 1% before the bell today after the announcement. However, the stock turned to green when the market opened today.
Most Popular
After a rollercoaster year, is Tesla (TSLA) stock a good bet?
In recent years, Tesla's (NASDAQ: TSLA) stock has often swung between record highs and sharp corrections, reflecting shifts in investor sentiment, broader economic conditions, and changes in its financial performance.
Dollar Tree (DLTR), Dollar General (DG): Discount stores remain key gainers in a value-conscious landscape
Discount retailers Dollar Tree, Inc. (NASDAQ: DLTR) and Dollar General Corporation (NYSE: DG) have seen their stocks gain more than 30% in the past three months. The dollar stores continue
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the